208 related articles for article (PubMed ID: 25313137)
21. Flesh and blood: the story of Vav1, a gene that signals in hematopoietic cells but can be transforming in human malignancies.
Katzav S
Cancer Lett; 2007 Oct; 255(2):241-54. PubMed ID: 17590270
[TBL] [Abstract][Full Text] [Related]
22. Oct4 promotes M2 macrophage polarization through upregulation of macrophage colony-stimulating factor in lung cancer.
Lu CS; Shiau AL; Su BH; Hsu TS; Wang CT; Su YC; Tsai MS; Feng YH; Tseng YL; Yen YT; Wu CL; Shieh GS
J Hematol Oncol; 2020 Jun; 13(1):62. PubMed ID: 32487125
[TBL] [Abstract][Full Text] [Related]
23. Gab2 promotes colony-stimulating factor 1-regulated macrophage expansion via alternate effectors at different stages of development.
Lee AW; Mao Y; Penninger JM; Yu S
Mol Cell Biol; 2011 Nov; 31(22):4563-81. PubMed ID: 21930791
[TBL] [Abstract][Full Text] [Related]
24. Tyrosine residues at the carboxyl terminus of Vav1 play an important role in regulation of its biological activity.
Lazer G; Pe'er L; Farago M; Machida K; Mayer BJ; Katzav S
J Biol Chem; 2010 Jul; 285(30):23075-85. PubMed ID: 20457609
[TBL] [Abstract][Full Text] [Related]
25. Vav1 inhibits RANKL-induced osteoclast differentiation and bone resorption.
Jang JS; Kang IS; Cha YN; Lee ZH; Dinauer MC; Kim YJ; Kim C
BMB Rep; 2019 Nov; 52(11):659-664. PubMed ID: 31072447
[TBL] [Abstract][Full Text] [Related]
26. Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphoma.
Cortes JR; Filip I; Albero R; Patiño-Galindo JA; Quinn SA; Lin WW; Laurent AP; Shih BB; Brown JA; Cooke AJ; Mackey A; Einson J; Zairis S; Rivas-Delgado A; Laginestra MA; Pileri S; Campo E; Bhagat G; Ferrando AA; Rabadan R; Palomero T
Cell Rep; 2022 Apr; 39(3):110695. PubMed ID: 35443168
[TBL] [Abstract][Full Text] [Related]
27. High nuclear level of Vav1 is a positive prognostic factor in early invasive breast tumors: a role in modulating genes related to the efficiency of metastatic process.
Grassilli S; Brugnoli F; Lattanzio R; Rossi C; Perracchio L; Mottolese M; Marchisio M; Palomba M; Nika E; Natali PG; Piantelli M; Capitani S; Bertagnolo V
Oncotarget; 2014 Jun; 5(12):4320-36. PubMed ID: 24962430
[TBL] [Abstract][Full Text] [Related]
28. Vav1 and PU.1 are recruited to the CD11b promoter in APL-derived promyelocytes: role of Vav1 in modulating PU.1-containing complexes during ATRA-induced differentiation.
Brugnoli F; Lambertini E; Varin-Blank N; Piva R; Marchisio M; Grassilli S; Miscia S; Capitani S; Bertagnolo V
Exp Cell Res; 2010 Jan; 316(1):38-47. PubMed ID: 19747912
[TBL] [Abstract][Full Text] [Related]
29. Vav1 and Vav2 play different roles in macrophage migration and cytoskeletal organization.
Wells CM; Bhavsar PJ; Evans IR; Vigorito E; Turner M; Tybulewicz V; Ridley AJ
Exp Cell Res; 2005 Nov; 310(2):303-10. PubMed ID: 16137676
[TBL] [Abstract][Full Text] [Related]
30. Vav1 increases Bcl-2 expression by selective activation of Rac2-Akt in leukemia T cells.
Wan YJ; Yang Y; Leng QL; Lan B; Jia HY; Liu YH; Zhang CZ; Cao Y
Cell Signal; 2014 Oct; 26(10):2202-9. PubMed ID: 24880064
[TBL] [Abstract][Full Text] [Related]
31. A miR-125b/CSF1-CX3CL1/tumor-associated macrophage recruitment axis controls testicular germ cell tumor growth.
Batool A; Wang YQ; Hao XX; Chen SR; Liu YX
Cell Death Dis; 2018 Sep; 9(10):962. PubMed ID: 30237497
[TBL] [Abstract][Full Text] [Related]
32. Colony-stimulating factor-1 and colony-stimulating factor-1 receptor co-expression is associated with disease progression in gastric cancer.
Okugawa Y; Toiyama Y; Ichikawa T; Kawamura M; Yasuda H; Fujikawa H; Saigusa S; Ohi M; Araki T; Tanaka K; Inoue Y; Tanaka M; Miki C; Kusunoki M
Int J Oncol; 2018 Aug; 53(2):737-749. PubMed ID: 29767252
[TBL] [Abstract][Full Text] [Related]
33. Blockade of tumor-derived colony-stimulating factor 1 (CSF1) promotes an immune-permissive tumor microenvironment.
Maldonado MDM; Schlom J; Hamilton DH
Cancer Immunol Immunother; 2023 Oct; 72(10):3349-3362. PubMed ID: 37505292
[TBL] [Abstract][Full Text] [Related]
34. Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical models.
Wolfe AR; Trenton NJ; Debeb BG; Larson R; Ruffell B; Chu K; Hittelman W; Diehl M; Reuben JM; Ueno NT; Woodward WA
Oncotarget; 2016 Dec; 7(50):82482-82492. PubMed ID: 27756885
[TBL] [Abstract][Full Text] [Related]
35. Effects of GM-CSF and M-CSF on tumor progression of lung cancer: roles of MEK1/ERK and AKT/PKB pathways.
Uemura Y; Kobayashi M; Nakata H; Kubota T; Bandobashi K; Saito T; Taguchi H
Int J Mol Med; 2006 Aug; 18(2):365-73. PubMed ID: 16820947
[TBL] [Abstract][Full Text] [Related]
36. VAV1: a new target in pancreatic cancer?
Denicola G; Tuveson DA
Cancer Biol Ther; 2005 May; 4(5):509-11. PubMed ID: 15970675
[TBL] [Abstract][Full Text] [Related]
37. Unraveling the Oncogenic Potential of VAV1 in Human Cancer: Lessons from Mouse Models.
Shalom B; Salaymeh Y; Risling M; Katzav S
Cells; 2023 Apr; 12(9):. PubMed ID: 37174676
[TBL] [Abstract][Full Text] [Related]
38. The association of Sam68 with Vav1 contributes to tumorigenesis.
Lazer G; Pe'er L; Schapira V; Richard S; Katzav S
Cell Signal; 2007 Dec; 19(12):2479-86. PubMed ID: 17855053
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment.
Chaturvedi P; Gilkes DM; Takano N; Semenza GL
Proc Natl Acad Sci U S A; 2014 May; 111(20):E2120-9. PubMed ID: 24799675
[TBL] [Abstract][Full Text] [Related]
40. Guanine nucleotide exchange factor Vav1 regulates perivascular homing and bone marrow retention of hematopoietic stem and progenitor cells.
Sanchez-Aguilera A; Lee YJ; Lo Celso C; Ferraro F; Brumme K; Mondal S; Kim C; Dorrance A; Luo HR; Scadden DT; Williams DA
Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9607-12. PubMed ID: 21606370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
